(Q38807392)
Statements
A novel, anisamide-targeted cyclodextrin nanoformulation for siRNA delivery to prostate cancer cells expressing the sigma-1 receptor (English)
Kathleen A Fitzgerald
Meenakshi Malhotra
Florence Sallas
James C Evans
22 December 2015